Opus Genetics (IRD) Capital Expenditures (QoQ) (2010 - 2019)
Opus Genetics (IRD) Capital Expenditures (QoQ) (2010 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Opus Genetics | 298.36 Mn | 209.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -52.95% |
| Sep 30, 2018 | 3,572.25% |
| Jun 30, 2018 | -61.39% |
| Mar 31, 2018 | -95.32% |
| Dec 31, 2017 | 1,455.33% |
| Sep 30, 2017 | -75.20% |
| Jun 30, 2017 | 251.70% |
| Mar 31, 2017 | 883.87% |
| Dec 31, 2016 | -46.41% |
| Sep 30, 2016 | -74.20% |
| Jun 30, 2016 | -36.58% |
| Mar 31, 2016 | -53.12% |
| Dec 31, 2015 | -75.56% |
| Sep 30, 2015 | 800.76% |
| Jun 30, 2015 | -43.88% |
| Mar 31, 2015 | -28.48% |
| Dec 31, 2014 | -30.40% |
| Sep 30, 2014 | 52.64% |
| Jun 30, 2014 | 176.93% |
| Mar 31, 2014 | 2.20% |